Published
At the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium, Pooja Ghatalia, MD, of Fox Chase Cancer Center, and Amanda Nizam, MD, of Cleveland Clinic, break down in detail the RETAIN-2 study, a phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.
- Category
- Oncology
Be the first to comment
Up Next
-
10:33
Daniel P. Petrylak - Clinical Trials in MIBC and NMIBC
-
07:48
Chemo cycles क्यों होते हैं? | Why Chemo is Given in Cycles & Not Continuously! | Dr Praveen Kammar
-
09:28
Advancing Neoadjuvant Therapies: Oncolytic Immunotherapy and Nivolumab in MIBC
-
04:54
Molecular Biomarkers and Risk Stratification in High-Risk Non-Muscle Invasive Bladder Cancer
-
14:05
How Immunotherapy Controls Cancer | New Cancer Treatment | Immunotherapy Future of Cancer Treatment
-
09:35
Expert Cancer Panel: Stage II EGFR mutant NSCLC s/p neoadjuvant chemo/RT/surgery with new RUL nodule
-
06:15
How Neoadjuvant Therapy Beats Postoperative Chemotherapy
-
06:44
Cancer Treatment में Chemo पहले या Surgery? | Is Chemo Necessary Before Surgery? | Dr Praveen Kammar
-
08:22
Bladder-Sparing with Systemic Therapy: Insights from RETAIN-2 and Future Directions
-
05:17
When Is Immunotherapy Given? Understanding Cancer Immunotherapy | Dr. Anup Toshniwal
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
